Skip to content
PICO Portalanswers from OpenAlex

Disulfiram suppresses NLRP3 inflammasome activation to treat peritoneal and gouty inflammation

PaperCitations, authors & open-access status

Disulfiram suppresses NLRP3 inflammasome activation to treat peritoneal and gouty inflammation is a paper indexed in PICO Portal from OpenAlex.

How many citations does Disulfiram suppresses NLRP3 inflammasome activation to treat peritoneal and gouty inflammation have?

PICO Portalcitation count

Disulfiram suppresses NLRP3 inflammasome activation to treat peritoneal and gouty inflammation has 107 citations in the OpenAlex counts PICO Portal stores.

When was Disulfiram suppresses NLRP3 inflammasome activation to treat peritoneal and gouty inflammation published?

PICO Portalyear

Disulfiram suppresses NLRP3 inflammasome activation to treat peritoneal and gouty inflammation has 2020 year in the PICO Portal index.

What is the open-access status of Disulfiram suppresses NLRP3 inflammasome activation to treat peritoneal and gouty inflammation?

PICO Portaloa status

Disulfiram suppresses NLRP3 inflammasome activation to treat peritoneal and gouty inflammation has closed oa status in the PICO Portal index.

What is the DOI of Disulfiram suppresses NLRP3 inflammasome activation to treat peritoneal and gouty inflammation?

PICO Portaldoi

The DOI for Disulfiram suppresses NLRP3 inflammasome activation to treat peritoneal and gouty inflammation is on the source record.

What is the PMID of Disulfiram suppresses NLRP3 inflammasome activation to treat peritoneal and gouty inflammation?

PICO Portalpmid

The PMID for Disulfiram suppresses NLRP3 inflammasome activation to treat peritoneal and gouty inflammation is on the source record.

What is the OpenAlex record for Disulfiram suppresses NLRP3 inflammasome activation to treat peritoneal and gouty inflammation?

PICO Portalopenalex

The OpenAlex for Disulfiram suppresses NLRP3 inflammasome activation to treat peritoneal and gouty inflammation is on the source record.

Related on PICO Portal

470M+ articles · 14-day free trial